Mode
Text Size
Log in / Sign up
N/A N=50 Treatment

Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain

Chronic Low Back Pain

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcome: Primary: Oswestry Disability Index (ODI) - 3 Months — -30.33 units on a scale — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Intracept (Device)
Age
Adult, Older Adult · 25+ yrs
Sex
All
Sponsor
Relievant Medsystems, Inc.
Primary completion
Feb 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Oswestry Disability Index (ODI) - 3 Months
-30.33 <0.001 sig
SECONDARY
Visual Analog Scale (VAS) - 3 Months
-3.79 <0.001 sig
SECONDARY
ODI Responder Rate - 3-Month
42
SECONDARY
VAS Responder Rate - 3 Month
36
SECONDARY
ODI -12 Months
-32.31 <0.001 sig
SECONDARY
VAS - 12 Month
-4.31
SECONDARY
ODI Responder Rate - 12-Month
40
SECONDARY
VAS Responder Rate - 12 Months
36
SECONDARY
VAS Reduction 50% or More - 12 Month
31

Summary

Prospective, single arm, open label, multi-center study to evaluated the effectiveness of intraosseous basivertebral nerve radiofrequency ablation using the Intracept System.

Eligibility Criteria

Inclusion Criteria

  • Skeletally mature subjects at least 25 years of age
  • Chronic low back pain for at least 6 months
  • Failure to respond to at least 6 months of non-operative conservative management
  • Oswestry Disability Index (ODI) at least 30 points
  • Modic changes Type 1 or 2

Exclusion Criteria

  • Current or history of vertebral cancer or spinal metastasis
  • History of a fragility fracture
  • Any back pathology related to trauma, evidence of vertebral compression fracture or other spinal pathology that could affect assessment of response to back pain
  • Disc extrusion or protrusion
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03266107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search